The following video is from Friday's Motley Fool Money roundtable discussion with host Chris Hill and analysts Ron Gross, James Early, and Charly Travers.
Intuitive Surgical (NASDAQ: ISRG ) reported double-digit sales growth and that first-quarter profits rose 32%. Despite the strong quarter, shares fell on Friday. In this segment, our analysts talk about Intuitive Surgical's business and how big a red flag the company's FDA investigation is for investors.
The relevant video segment can be found between 14:25 and 15:56.
Are stories of this demise greatly exaggerated?
Recently, some investors have questioned Intuitive Surgical's future. However, Intuitive Surgical expert Karl Thiel believes a visible path to long-term growth persists. Will Intuitive capitalize or be crushed by unforeseen pitfalls? His report highlights all of the key opportunities and risks facing the company -- and includes a full year of ongoing updates as key new hits -- so be sure to claim your copy by clicking here now.